Xie, Y. et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ 365, l1580 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Eroglu, T. E., Coronel, R. & Gislason, G. H. Use of proton pump inhibitors is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nested case-control study. Eur. Heart J. Cardiovasc. Pharmacother. 10, 413–419 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Famularo, G., Gasbarrone, L. & Minisola, G. Hypomagnesemia and proton-pump inhibitors. Expert Opin. Drug Saf 12, 709–716 (2013).

Article  CAS  PubMed  Google Scholar 

Chrysant, S. G. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias. Expert Rev. Cardiovasc. Ther. 17, 345–351 (2019).

Article  CAS  PubMed  Google Scholar 

Lazzerini, P. E. et al. Proton pump inhibitors and serum magnesium levels in patients with torsades de pointes. Front. Pharmacol. 9, 363 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Lazzerini, P. E. et al. Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US veterans. Circ. Arrhythm. Electrophysiol. 14, e010042 (2021).

Article  CAS  PubMed  Google Scholar 

Fan, W., Liu, H., Shen, Y. & Hong, K. The association of proton pump inhibitors and QT interval prolongation in critically ill patients. Cardiovasc. Drugs Ther. 38, 517–525 (2024).

Article  CAS  PubMed  Google Scholar 

Lorberbaum, T. et al. Coupling data mining and laboratory experiments to discover drug interactions causing QT prolongation. J. Am. Coll. Cardiol. 68, 1756–1764 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai, A. D. et al. Ceftriaxone and the risk of ventricular arrhythmia, cardiac arrest, and death among patients receiving lansoprazole. JAMA Netw. Open 6, e2339893 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Mitsuboshi, S., Imai, S., Kizaki, H. & Hori, S. Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database. J. Infect. 89, 106202 (2024).

Article  CAS  PubMed  Google Scholar